Mary Weyrick

Mary Weyrick is the CEO of InBody BWA since January 2023, focusing on developing strategies to expand the applications of InBody devices in clinical and research settings for chronic disease. Prior to this role, Mary served at InBody USA from 2008 to 2023 in various capacities, including Assistant Director of Clinical Research, where responsibilities included forming research and medical partnerships to achieve significant healthcare outcomes. Additionally, Mary held the position of West Division Manager, overseeing business activities for the western United States, and began as an InBody Specialist. Mary earned a Bachelor of Arts in Art History from the University of Toronto between 1998 and 2001.